- Filed
- May 9, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 7, 2025 | 3.04M sh |
| Short Term Investments | Q1 2025 · Mar 31, 2025 | $20.33M |
| Short Term Investments | Q1 2025 · Dec 31, 2024 | $23M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $3.77M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $3.79M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $5.27M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $6.01M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $10.32M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $10.72M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $27.11M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $29.71M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $34.02M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $36.48M |
| Shares Diluted restated | Q1 2025 · Mar 31, 2024 | 3.89M sh |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $13.62M |
| Stockholders Equity restated | Q1 2025 · Mar 31, 2024 | $21.52M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $6.11M |
| Eps Diluted restated | Q1 2025 · Mar 31, 2024 | $3.46 |
| Eps Basic restated | Q1 2025 · Mar 31, 2024 | $4.67 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $1.3M |
| Rd Expense restated | Q1 2025 · Mar 31, 2024 | $1.68M |
| Net Income | Q1 2025 · Mar 31, 2024 | $13.45M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $13.22M |